The Australian ARV Guideline Committee acknowledges the updated U.S. Department of Health and Human Services HIV Guidelines (September 2025). Updates to the Australian ARV Guideline Commentary are currently on hold, pending a major update planned for late 2026. Feedback or questions can be directed to [email protected].
In February 2005, the Australian Health Minister’s Advisory Committee on HIV and STI endorsed the US Department of Health and Human Services (DHHS) Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents and requested that ASHM facilitate the production of a regularly updated commentary on those Guidelines relevant to Australia. The US DHHS has agreed to this adoption and adaptation process.
The ASHM Sub-Committee for Guidance on HIV Management provides the commentary and reviews the guidelines on a regular basis. It is the intention of the sub-committee to review the guidelines after every major revision of the US DHHS guidelines, as well as more frequently if a particular issue comes to the notice of the committee which requires more immediate action (such as the contraindication of prescription of a certain drug in a particular condition).
